Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Lung Cancer

Choosing Wisely Mumbai 2023: Common Sense in Oncology

Published: 6 Nov 2023

Views: 130

Rating:

Save

Dr Sabita Jiwnani - Tata Memorial Hospital, Mumbai, India

Dr Sabita Jiwnani speaks at the ecancer Choosing Wisely Mumbai 2023: Common Sense in Oncology, which was held in Tata Memorial Hospital, on 1st of November 2023.

Related Videos

Advancements in paediatric Acute lymphoblastic leukemia management

Dr Ruchi Aujla - Balco Medical Center, Raipur, India

Advancements in paediatric Acute lymphoblastic leukemia management ( Dr Ruchi Aujla - Balco Medical Center, Raipur, India )

Multiple myeloma In Rwanda: The need for further research

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda

Multiple myeloma In Rwanda: The need for further research ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )

Addressing the rise of multiple myeloma in Rwanda

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda

Addressing the rise of multiple myeloma in Rwanda ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )

EAU 2024: Bladder cancer latest

Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea...

EAU 2024: Bladder cancer latest ( Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio )

Haemato-oncological Cancers

Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India

Haemato-oncological Cancers ( Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India )

Head and Neck Cancers

Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai

Head and Neck Cancers ( Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai )

Dr Nita Nair - Apollo Cancer Centres, Mumbai

Breast Cancer ( Dr Nita Nair - Apollo Cancer Centres, Mumbai )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for...

Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC ( Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer